Dermatomyositis, Polymyositis research hub

A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants receiving Standard of Care

This study is testing a new drug, Enpatoran, for dermatomyositis and polymyositis. Researchers want to see if it's safe and helps improve symptoms when added to usual care.